Correlation Between Virax Biolabs and PaxMedica, Common
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and PaxMedica, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and PaxMedica, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and PaxMedica, Common Stock, you can compare the effects of market volatilities on Virax Biolabs and PaxMedica, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of PaxMedica, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and PaxMedica, Common.
Diversification Opportunities for Virax Biolabs and PaxMedica, Common
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Virax and PaxMedica, is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and PaxMedica, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PaxMedica, Common Stock and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with PaxMedica, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PaxMedica, Common Stock has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and PaxMedica, Common go up and down completely randomly.
Pair Corralation between Virax Biolabs and PaxMedica, Common
If you would invest 86.00 in PaxMedica, Common Stock on August 28, 2024 and sell it today you would earn a total of 0.00 from holding PaxMedica, Common Stock or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
Virax Biolabs Group vs. PaxMedica, Common Stock
Performance |
| Timeline |
| Virax Biolabs Group |
| PaxMedica, Common Stock |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Virax Biolabs and PaxMedica, Common Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and PaxMedica, Common
The main advantage of trading using opposite Virax Biolabs and PaxMedica, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, PaxMedica, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PaxMedica, Common will offset losses from the drop in PaxMedica, Common's long position.| Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. HCW Biologics | Virax Biolabs vs. Scpharmaceuticals | Virax Biolabs vs. Milestone Pharmaceuticals |
| PaxMedica, Common vs. Quoin Pharmaceuticals Ltd | PaxMedica, Common vs. Revelation Biosciences | PaxMedica, Common vs. Unicycive Therapeutics | PaxMedica, Common vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |